231 related articles for article (PubMed ID: 33327867)
1. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
2. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
4. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
5. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Ding XZ; Zhang SQ; Deng XL; Qiang JH
Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
[TBL] [Abstract][Full Text] [Related]
6. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM
BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332
[TBL] [Abstract][Full Text] [Related]
8. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia.
Xin F; Liu P; Ma CF
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4846-4851. PubMed ID: 27981553
[TBL] [Abstract][Full Text] [Related]
9. microRNA Profile Associated with Positive Lymph Node Metastasis in Early-Stage Cervical Cancer.
Barquet-Muñoz SA; Pedroza-Torres A; Perez-Plasencia C; Montaño S; Gallardo-Alvarado L; Pérez-Montiel D; Herrera-Montalvo LA; Cantú-de León D
Curr Oncol; 2022 Jan; 29(1):243-254. PubMed ID: 35049697
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
11. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
12. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
13. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
15. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
16. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
Aftab M; Poojary SS; Seshan V; Kumar S; Agarwal P; Tandon S; Zutshi V; Das BC
Sci Rep; 2021 May; 11(1):10323. PubMed ID: 33990639
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
[TBL] [Abstract][Full Text] [Related]
19. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
20. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
